Lupin receives USFDA approval for Methylprednisolone


Lupin has received USFDA approval for Methylprednisolone Tablets USP, 2 mg, 4 mg, 8 mg, 16 mg and 32 mg which is a generic version of Pharmacia and Upjohn’s Medrol tablets. The drug is prescribed for to treat endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, etc.,

According to market estimates,, the drug Methylprednisolone Tablets had annual sales of approximately $114.3 million in the US.

Company Profile : Lupin Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.